Literature DB >> 27438765

A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.

Devin Sok1, Matthias Pauthner2, Bryan Briney2, Jeong Hyun Lee3, Karen L Saye-Francisco2, Jessica Hsueh2, Alejandra Ramos1, Khoa M Le2, Meaghan Jones2, Joseph G Jardine2, Raiza Bastidas2, Anita Sarkar3, Chi-Hui Liang2, Sachin S Shivatare4, Chung-Yi Wu4, William R Schief5, Chi-Huey Wong4, Ian A Wilson6, Andrew B Ward3, Jiang Zhu7, Pascal Poignard1, Dennis R Burton8.   

Abstract

The dense patch of high-mannose-type glycans surrounding the N332 glycan on the HIV envelope glycoprotein (Env) is targeted by multiple broadly neutralizing antibodies (bnAbs). This region is relatively conserved, implying functional importance, the origins of which are not well understood. Here we describe the isolation of new bnAbs targeting this region. Examination of these and previously described antibodies to Env revealed that four different bnAb families targeted the (324)GDIR(327) peptide stretch at the base of the gp120 V3 loop and its nearby glycans. We found that this peptide stretch constitutes part of the CCR5 co-receptor binding site, with the high-mannose patch glycans serving to camouflage it from most antibodies. GDIR-glycan bnAbs, in contrast, bound both (324)GDIR(327) peptide residues and high-mannose patch glycans, which enabled broad reactivity against diverse HIV isolates. Thus, as for the CD4 binding site, bnAb effectiveness relies on circumventing the defenses of a critical functional region on Env.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27438765      PMCID: PMC4990068          DOI: 10.1016/j.immuni.2016.06.026

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  73 in total

1.  Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

Authors: 
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

3.  Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection.

Authors:  J A Nelson; F Baribaud; T Edwards; R Swanstrom
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.

Authors:  Rui Kong; Kai Xu; Tongqing Zhou; Priyamvada Acharya; Thomas Lemmin; Kevin Liu; Gabriel Ozorowski; Cinque Soto; Justin D Taft; Robert T Bailer; Evan M Cale; Lei Chen; Chang W Choi; Gwo-Yu Chuang; Nicole A Doria-Rose; Aliaksandr Druz; Ivelin S Georgiev; Jason Gorman; Jinghe Huang; M Gordon Joyce; Mark K Louder; Xiaochu Ma; Krisha McKee; Sijy O'Dell; Marie Pancera; Yongping Yang; Scott C Blanchard; Walther Mothes; Dennis R Burton; Wayne C Koff; Mark Connors; Andrew B Ward; Peter D Kwong; John R Mascola
Journal:  Science       Date:  2016-05-13       Impact factor: 47.728

5.  Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor.

Authors:  Pirada Suphaphiphat; Max Essex; Tun-Hou Lee
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

6.  Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.

Authors:  C L Kuiken; J J de Jong; E Baan; W Keulen; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

8.  Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Chaim A Schramm; Jason Gorman; Penny L Moore; Jinal N Bhiman; Brandon J DeKosky; Michael J Ernandes; Ivelin S Georgiev; Helen J Kim; Marie Pancera; Ryan P Staupe; Han R Altae-Tran; Robert T Bailer; Ema T Crooks; Albert Cupo; Aliaksandr Druz; Nigel J Garrett; Kam H Hoi; Rui Kong; Mark K Louder; Nancy S Longo; Krisha McKee; Molati Nonyane; Sijy O'Dell; Ryan S Roark; Rebecca S Rudicell; Stephen D Schmidt; Daniel J Sheward; Cinque Soto; Constantinos Kurt Wibmer; Yongping Yang; Zhenhai Zhang; James C Mullikin; James M Binley; Rogier W Sanders; Ian A Wilson; John P Moore; Andrew B Ward; George Georgiou; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris; Peter D Kwong; Lawrence Shapiro; John R Mascola
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

9.  Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.

Authors:  Penny L Moore; Elin S Gray; C Kurt Wibmer; Jinal N Bhiman; Molati Nonyane; Daniel J Sheward; Tandile Hermanus; Shringkhala Bajimaya; Nancy L Tumba; Melissa-Rose Abrahams; Bronwen E Lambson; Nthabeleng Ranchobe; Lihua Ping; Nobubelo Ngandu; Quarraisha Abdool Karim; Salim S Abdool Karim; Ronald I Swanstrom; Michael S Seaman; Carolyn Williamson; Lynn Morris
Journal:  Nat Med       Date:  2012-10-21       Impact factor: 53.440

10.  Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.

Authors:  A Buchacher; R Predl; K Strutzenberger; W Steinfellner; A Trkola; M Purtscher; G Gruber; C Tauer; F Steindl; A Jungbauer
Journal:  AIDS Res Hum Retroviruses       Date:  1994-04       Impact factor: 2.205

View more
  72 in total

1.  Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth.

Authors:  Xuejun Chen; Tongqing Zhou; Stephen D Schmidt; Hongying Duan; Cheng Cheng; Gwo-Yu Chuang; Ying Gu; Mark K Louder; Bob C Lin; Chen-Hsiang Shen; Zizhang Sheng; Michelle X Zheng; Nicole A Doria-Rose; M Gordon Joyce; Lawrence Shapiro; Ming Tian; Frederick W Alt; Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2021-01-15       Impact factor: 31.745

Review 2.  What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise.

Authors:  Dennis R Burton
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

Review 3.  How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.

Authors:  Marie Pancera; Anita Changela; Peter D Kwong
Journal:  Curr Opin HIV AIDS       Date:  2017-05       Impact factor: 4.283

4.  Structure and Immune Recognition of the HIV Glycan Shield.

Authors:  Max Crispin; Andrew B Ward; Ian A Wilson
Journal:  Annu Rev Biophys       Date:  2018-03-29       Impact factor: 12.981

5.  Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys.

Authors:  Boris Julg; Amarendra Pegu; Peter Abbink; Jinyan Liu; Amanda Brinkman; Katherine Molloy; Shanell Mojta; Abishek Chandrashekar; Katherine Callow; Keyun Wang; Xuejun Chen; Stephen D Schmidt; Jinghe Huang; Richard A Koup; Michael S Seaman; Brandon F Keele; John R Mascola; Mark Connors; Dan H Barouch
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 6.  Targeting the N332-supersite of the HIV-1 envelope for vaccine design.

Authors:  Thandeka Moyo; Dale Kitchin; Penny L Moore
Journal:  Expert Opin Ther Targets       Date:  2020-04-27       Impact factor: 6.902

Review 7.  Structural principles controlling HIV envelope glycosylation.

Authors:  Anna-Janina Behrens; Max Crispin
Journal:  Curr Opin Struct Biol       Date:  2017-03-29       Impact factor: 6.809

8.  HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

Authors:  Todd Bradley; Guang Yang; Olga Ilkayeva; T Matt Holl; Ruijun Zhang; Jinsong Zhang; Sampa Santra; Christopher B Fox; Steve G Reed; Robert Parks; Cindy M Bowman; Hilary Bouton-Verville; Laura L Sutherland; Richard M Scearce; Nathan Vandergrift; Thomas B Kepler; M Anthony Moody; Hua-Xin Liao; S Munir Alam; Roger McLendon; Jeffrey I Everitt; Christopher B Newgard; Laurent Verkoczy; Garnett Kelsoe; Barton F Haynes
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

9.  Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates.

Authors:  Kevin O Saunders; Nathan I Nicely; Kevin Wiehe; Mattia Bonsignori; R Ryan Meyerhoff; Robert Parks; William E Walkowicz; Baptiste Aussedat; Nelson R Wu; Fangping Cai; Yusuf Vohra; Peter K Park; Amanda Eaton; Eden P Go; Laura L Sutherland; Richard M Scearce; Dan H Barouch; Ruijun Zhang; Tarra Von Holle; R Glenn Overman; Kara Anasti; Rogier W Sanders; M Anthony Moody; Thomas B Kepler; Bette Korber; Heather Desaire; Sampa Santra; Norman L Letvin; Gary J Nabel; David C Montefiori; Georgia D Tomaras; Hua-Xin Liao; S Munir Alam; Samuel J Danishefsky; Barton F Haynes
Journal:  Cell Rep       Date:  2017-02-28       Impact factor: 9.423

10.  An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes.

Authors:  Adam S Dingens; Dana Arenz; Haidyn Weight; Julie Overbaugh; Jesse D Bloom
Journal:  Immunity       Date:  2019-01-29       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.